Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Raymond James Downgrades NexImmune to Market Perform

Raymond James Downgrades NexImmune to Market Perform

Raymond James analyst Steven Seedhouse downgrades NexImmune (NASDAQ:NEXI) from Outperform to Market Perform.

byBenzinga Newsdesk

November 15, 2022

1 minute read

Raymond James analyst Steven Seedhouse downgrades NexImmune (NASDAQ:NEXI) from Outperform to Market Perform.

Toyota Motor Unveils New Tacoma Model, Plans To Rule Mid-Size Pickup Truck Market

By Lekha Gupta

May 19, 7:42 AM

Toyota Motor Corp (NYSE:TM) announced a fourth-generation model of its bestselling Tacoma truck, which will be available in early 2024.…

SZKMF

Events
News

Southwest Airlines CEO Says Fully Expect Boeing To Get Extension For Certification Of Max 7 Aircraft

By Benzinga Newsdesk

December 7, 2:44 PM

- Investor Day

New York On Track To Become Next Cannabis Capital, But State Sen. Warns Not To Imitate California

By Jelena Martinovic

December 28, 11:23 AM

The first adult-use cannabis sales in New York began on Dec. 29, nearly 20 months after former Gov. Andrew Cuomo signed recreational marijuana into law.

ACRDF

Truist Securities Maintains Buy on NXP Semiconductors, Raises Price Target to $210

By Benzinga Newsdesk

February 1, 9:14 AM

Truist Securities analyst William Stein maintains NXP Semiconductors (NASDAQ:NXPI) with a Buy and raises the price target from $209 to $210.

NXPI

Raymond James Downgrades NexImmune to Market Perform

Related Posts

Toyota Motor Unveils New Tacoma Model, Plans To Rule Mid-Size Pickup Truck Market

Southwest Airlines CEO Says Fully Expect Boeing To Get Extension For Certification Of Max 7 Aircraft

New York On Track To Become Next Cannabis Capital, But State Sen. Warns Not To Imitate California

Truist Securities Maintains Buy on NXP Semiconductors, Raises Price Target to $210